Tulip BioMed, Inc., formerly known as Cell Bio-Systems, Inc. (OTC: CBSI), a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, today announced it has launched sales of its new disposable surgical instruments for the removal of soft tissue and fluid for the plastic surgery market after receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for its cannula devices.
